Semaglutide

Semaglutide is a GLP1 receptor agonist. GLP1 is an incretin hormone that increases insulin and decreases glucagon (the hormone responsible for eating), both of which lead to a decrease in blood sugar. These reactions also lead to delayed gastric emptying, which sends signals to the brain that the stomach is full.

Semaglutide injections are once-weekly injections that are indicated for type 2 diabetes or weight loss. This medication can reduce the risk of cardiac events including stroke, heart attack, or death in patients with type 2 diabetes. For weight loss, Semaglutide reduces hunger and increases energy. This can help you eat less and lead to weight loss.